Home > Cashflow Statement > VALIANT LABORATORIES

VALIANT LABORATORIES
Cashflow Statement

AD     Remove this Ad

VALIANT LABORATORIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023
Profit Before Tax₹-1.51 Cr₹-0.77 Cr₹38 Cr
Adjustment ₹4.29 Cr₹2.04 Cr₹1.56 Cr
Changes In working Capital ₹-3.93 Cr₹-0.37 Cr₹25 Cr
Cash Flow after changes in Working Capital ₹-1.15 Cr₹0.90 Cr₹65 Cr
Cash Flow from Operating Activities ₹1.31 Cr₹1.89 Cr₹56 Cr
Cash Flow from Investing Activities ₹-53 Cr₹-144 Cr₹-55 Cr
Cash Flow from Financing Activities ₹45 Cr₹152 Cr₹-0.93 Cr
Net Cash Inflow / Outflow ₹-6.80 Cr₹10 Cr₹-0.05 Cr
Opening Cash & Cash Equivalents ₹12 Cr₹1.26 Cr₹1.31 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ---
Cash & Cash Equivalent of Subsidiaries under liquidations ---
Translation adjustment on reserves / op cash balalces frgn subsidiaries ---
Effect of Foreign Exchange Fluctuations ---
Closing Cash & Cash Equivalent ₹4.92 Cr₹12 Cr₹1.26 Cr

Compare Cashflow Statement of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹331.4 Cr 18.1% 3.1% -28.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹101,445.0 Cr -3.3% -6.9% -17% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

18.1%

3.1%

-28.5%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses